Pleryon Therapeutics Presents at ARVO 2025

At this year's Association for Research in Vision and Ophthalmology (ARVO) annual meeting, our team presented compelling preclinical data on P002, our novel lubricin-mimetic diblock copolymer for dry eye disease. The findings demonstrate P002's potential to address critical limitations of current therapies.

Meet us at our poster:

Session Number: 221

Session Title: Dry Eye: Non-clinical Aspects II

Session Date/Times: May 5, 2025 from 8:30 AM to 10:15 AM